Form 4: Woodward CEO Exercises Options, Sells Shares
Insider Transaction Report
Woodward, Inc. Chairman and CEO Charles P. Blankenship exercised stock options and subsequently sold 10,000 shares of common stock over two days in early March 2026.
Summary
- Charles P. Blankenship, Chairman of the Board and CEO of Woodward, Inc., engaged in transactions involving the company's common stock on March 3 and March 4, 2026.
- On March 3, 2026, Blankenship exercised non-qualified stock options to acquire 5,000 shares of Woodward, Inc. Common Stock at an exercise price of $98.34 per share.
- Immediately following the option exercise on March 3, 2026, Blankenship sold 5,000 shares of Common Stock in multiple open market transactions at weighted average prices ranging from $377.84 to $394.55 per share.
- On March 4, 2026, Blankenship again exercised non-qualified stock options to acquire another 5,000 shares of Woodward, Inc. Common Stock at an exercise price of $98.34 per share.
- Following this second option exercise on March 4, 2026, Blankenship sold 5,000 shares of Common Stock in multiple open market transactions at weighted average prices ranging from $382.06 to $387.97 per share.
- All sales were conducted under a Rule 10b5-1 trading plan adopted on December 2, 2025.
- After these transactions, Blankenship directly beneficially owns 65,829 shares of Woodward, Inc. Common Stock and indirectly owns 407 shares through the Woodward Retirement Savings Plan.
- The non-qualified stock options, which expire on May 9, 2032, became exercisable as to 25% of the shares on May 9, 2023, and 25% each one-year anniversary thereafter.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive event. While insider selling can sometimes be a red flag, the pre-planned nature via a 10b5-1 plan mitigates concerns, and the executive realized substantial gains from vested options.
Positives
- The executive realized significant gains by exercising options at $98.34 and selling shares at prices ranging from $377.84 to $394.55.
- The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, indicating a planned liquidity event rather than a reaction to recent negative news.
Negatives
- Significant insider selling by the Chairman and CEO could be perceived negatively by some investors, even if pre-planned.
- The total direct beneficial ownership decreased by 10,000 shares following the transactions.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that insider selling, even when pre-planned via a Rule 10b5-1 plan, is a common occurrence for executives managing their personal portfolios and diversifying wealth. The significant spread between the exercise price and sale price indicates a substantial personal gain, which is typical for long-tenured executives with vested options.
Stakeholder Impact
- Shareholders: May view the executive's sale as a signal, though the 10b5-1 plan suggests it's not based on new negative information. The executive's remaining significant holdings indicate continued alignment.
- Employees: No direct impact mentioned.
- Customers/Suppliers/Creditors: No direct impact mentioned.
Key Dates
| Date | Description |
|---|---|
| 2023-05-09 | Date when 25% of the non-qualified stock options became exercisable. |
| 2025-12-02 | Date the Rule 10b5-1 trading plan was adopted. |
| 2026-03-03 | Date of option exercise and subsequent sale of 5,000 shares of common stock. |
| 2026-03-04 | Date of option exercise and subsequent sale of 5,000 shares of common stock. |
| 2026-03-05 | Date the Form 4 was signed. |
| 2032-05-09 | Expiration date of the non-qualified stock options. |
Recommendation
holdThe transactions represent a routine, pre-planned exercise of options and subsequent sale of shares by a senior executive for personal financial planning. The sales were executed under a Rule 10b5-1 plan, which typically signals a non-discretionary transaction rather than a reaction to new company-specific information. While insider selling can sometimes be a concern, the context of a 10b5-1 plan and the executive's continued significant holdings suggest no immediate negative implications for the company's fundamentals. Therefore, a 'hold' recommendation is appropriate, as this filing does not provide new information warranting a change in investment thesis.
Keywords
Woodward Inc., WWD, Insider Trading, Form 4, Stock Options, Executive Compensation, Charles P. Blankenship, Rule 10b5-1, Share Sale, Director Transaction, CEO Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.